Galal A Alshafie from 2978 Leatherlips Trl, Dublin, OH 43017, age 70, Phone: 614 356-1421

Galal Alshafie Phones & Addresses

g***[email protected]

C-Linked Glucuronide Of N-(4-Hydroxybenzyl) Retinone, Analogs Thereof, And Method Of Using The Same To Inhibit Neoplastic Cell Growth
view source
US Patent:

8026220, Sep 27, 2011
Filed:

Jan 22, 2009
Appl. No.:

12/357737
Inventors:

Margaret Clagett-Dame - Deerfield WI, US
Joel R. Walker - Tucson AZ, US
Hussein Abou-Issa - Columbus OH, US
Galal A. Alshafie - Columbus OH, US
Assignee:

Wisconsin Alumni Research Foundation - Madison WI
International Classification:

A01N 43/04
A61K 31/70
C07H 1/00
C07C 49/00
US Classification:

514 23, 536 111, 568329
Abstract:

Compounds of the formula:.

C-Linked Glucuronide Of N-(4-Hydroxybenzyl) Retinone, Analogs Thereof, And Method Of Using The Same To Inhibit Neoplastic Cell Growth
view source
US Patent:

20060287255, Dec 21, 2006
Filed:

May 3, 2006
Appl. No.:

11/416907
Inventors:

Margaret Clagett-Dame - Deerfield WI, US
Robert Curley - Dublin OH, US
Joel Walker - Tucson AZ, US
Hussein Abou-Issa - Columbus OH, US
Galal Alshafie - Columbus OH, US
International Classification:

A61K 31/7034
C07H 15/04
US Classification:

514025000, 536120000
Abstract:

Compounds of the formula: are described, along with pharmaceutical compositions containing these compounds, and methods of using the compounds to prevent and to treat cancer in mammals, including humans.

C-Linked Glucuronide Of N-(4-Hydroxybenzyl) Retinone, Analogs Thereof, And Methods Of Using The Same To Inhibit Neoplastic Cell Growth
view source
US Patent:

20110212906, Sep 1, 2011
Filed:

May 12, 2011
Appl. No.:

13/106537
Inventors:

Margaret Clagett-Dame - Deerfield WI, US
Joel R. Walker - Tucson AZ, US
Hussein Abou-Issa - Columbus OH, US
Galal A. Alshafie - Columbus OH, US
International Classification:

A61K 31/7034
C07H 7/04
C07C 49/225
A61K 31/12
A61P 35/00
US Classification:

514 23, 536 111, 568329, 514683
Abstract:

Compounds of the formula:are described, along with pharmaceutical compositions containing these compounds, and methods of using the compounds to prevent and to treat cancer in mammals, including humans.